Treatment of Anhedonia in Depression

Initial Assessment and Recognition

The American College of Physicians recommends screening for anhedonia specifically using the two-item PHQ-9 approach, assessing for low mood and loss of pleasure or interest occurring more than half the time in the past two weeks, with a cutoff of ≥8 indicating clinically significant depression requiring treatment 1

The American College of Physicians strongly recommends CBT as first-line treatment with equivalent effectiveness to antidepressants for moderate depression, with a strength of evidence rated as high 2
Behavioral activation within CBT specifically targets anhedonic symptoms by re-engaging patients with pleasurable activities, with moderate-strength evidence 4

The American College of Physicians recommends continuing antidepressant treatment for 9-12 months after recovery to prevent relapse, with a strength of evidence rated as moderate 4
For first episodes, maintaining treatment for 4-9 months after satisfactory response, and for recurrent episodes, continuing treatment for ≥1 year, with a strength of evidence rated as high 2, 3

For mild depression with anhedonia, starting with CBT alone, specifically incorporating behavioral activation, with moderate-strength evidence 2, 3
For moderate to severe depression with anhedonia, initiating either CBT or second-generation antidepressants with anti-anhedonic properties, with high-strength evidence 2, 3, 4

The American College of Physicians recommends not using SSRIs or SNRIs as first-line agents when anhedonia is the predominant symptom, as they show limited efficacy and may worsen anhedonia, with a strength of evidence rated as high 4
Not discontinuing treatment prematurely before 9-12 months after recovery, with a strength of evidence rated as moderate 4
Not treating anhedonia with benzodiazepines, which are not indicated for depressive symptoms, with a strength of evidence rated as high 4
Reviewing current medications and considering dose reduction or switching if medication-induced anhedonia is suspected, with a strength of evidence rated as moderate 6